Back to STIFEL FINANCIAL CORP STIFEL FINANCIAL CORP

AXSMAXSM

Showing 5 of 17 quarters

Position history for STIFEL FINANCIAL CORPSTIFEL FINANCIAL CORP's holdings in AXSOME THERAPEUTICS INC.

Yes. Stifel Financial holds 7,421 shares of AXSM (Axsome Therapeutics), worth $1.8M, as of its Q2 2026 13F filing. It increased the position by 1,501 shares (+25.4%) from Q1 2026. Stifel Financial has held AXSM since Q2 2025, across 5 quarterly 13F filings.

Current Value

$1.8M

Current Shares

7,421

Total Value Change

+$1.4M

Total Shares Change

+3,099

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
7,421
+25.4%
$1.8M0.0%$244.77
32
2026-Q1
Increased
5,920
+0.9%
$1M0.0%$169.02
25
2025-Q4
Increased
5,868
+6.6%
$1.1M0.0%$182.64
27
2025-Q3
Increased
5,507
+27.4%
$668,8430.0%$121.45
30
2025-Q2
New
4,322
—
$451,1780.0%$104.39
33

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used